Low-coverage massively parallel genome sequencing for non-invasive prenatal testing (NIPT) of common aneuploidies is one of the most rapidly adopted and relatively low-cost DNA tests. Since aggregation of reads from a large number of samples allows overcoming the problems of extremely low coverage of individual samples, we describe the possible re-use of the data generated during NIPT testing for genome scale population specific frequency determination of small DNA variants, requiring no additional costs except of those for the NIPT test itself. We applied our method to a data set comprising of 1,548 original NIPT test results and evaluated the findings on different levels, from in silico population frequency comparisons up to wet lab validation analyses using a gold-standard method. The revealed high reliability of variant calling and allelic frequency determinations suggest that these NIPT data could serve as valuable alternatives to large scale population studies even for smaller countries around the world.
Introduction
Although the costs of sequencing are continually dropping (Erlich 2015) , large-scale human genome-related projects (Carrasco-Ramiro et al. 2017 ) still remain to be associated with substantial costs and a certain timeframe to complete. Further data aggregation efforts are, however, still in place to increase resolution and improve power at low allele frequencies (Lek et al. 2016) . On the other hand, a low-cost genomic test readily used in routine clinical practice for determination of common fetal chromosomal aberrations and selected copy-number variants is becoming commonplace (Minear et al. 2015; Gregg et al. 2016) . Non-invasive prenatal testing (NIPT) most commonly uses very low-coverage massively parallel wholegenome sequencing of total plasma DNA of pregnant women (Minarik et al. 2015) . Although high-quality single nucleotide variant (SNVs) and small insertion-deletion (indels) calls can be observed even in individual reads, reliable genotyping through one mapped read per genomic position cannot be considered appropriate in individual patients. Hypothetically, however, the vast amount of data generated during NIPT testing worldwide (Shendure et al. 2017 ) could be used for whole-genome-scale population specific frequency determination of small sequence variants. The rationale behind our vision lies in overcoming the problems of extremely low coverage of individual samples by aggregation of reads from a large cohort routinely tested. To evaluate the possibilities/limitations of such an approach, we analysed data generated by massively parallel low-coverage whole-genome sequencing of plasma DNA of 1,548 pregnant women undergoing NIPT procedure in Slovakia.
Results
To evaluate the above mentioned possibilities, 1,548 individual binary alignment map (BAM) files were analysed, revealing a median per sample genome coverage of 20.36% (0.2x), while
Figure 1: Schematic sequential representation of the performed analytical steps, the applied tools, filters and statistical results. BAM = binary alignment map; DP = depth of coverage; GRCh = Genome Reference Consortium human; MAF = minor allele frequency; NIPT = noninvasive prenatal testing; SD = standard deviation; SNVs = single nucleotide variants.
Figure 2:
Characteristics of genome coverage and variant distributions, clustered by 1,000,000 bases. Dark grey regions = centromeres; light grey regions = unmappable genomic regions which are not assembled in the reference genome (N regions). Track numbering from the inner circle (axis of each track corresponds from low value to high value from the inside to the outside): Track 1: GC content of the genome sequence; Track 2: Genome coverage and coverage depth. Distribution of the uncovered regions strongly correlates with the unassembled regions of the genome consisting mainly of telomeres, centromeres, short-arms of acrocentric chromosomes (chr13, 14, 15, 21, 22, Y) and large heterochromatic regions of chr1, 9, 16, Y (Li and Freudenberg 2014) ; Track 3: Ensembl-based gene density of the genome. Track 4-7: Novel variant positions, lacking records in dbSNP (137,580), separated to complex variants (Track 4), variants in repetitive regions (Track 5), variants in regions that are not present in GRCh37 (Track 6) and novel variants with so far unidentified aetiology marked as "unresolved" (Track 7); Track 8: Variant density for those 6,485,313 variants that have frequency higher than 5% and are already present in dbSNP (purple dots = ExAC data set; red dots = our data set). Multiply covered regions in a single individual, however, pose a problem in determination of the total number of alleles for frequency calculations, thus having a potential to skew the resulting calculated allelic frequencies for variants detected in these particular regions. Since our specific simulations, performed to estimate the effect of this factor, suggested substantial increase of simulated MAF variance caused by duplicates (Suppl. Fig. 1 ), we decided to remove all overlapping reads to ensure uniqueness of observed alleles. Reads from individual BAM files were filtered in such way that only the first of overlapping reads were kept for further analysis. Due the fact that one whole read was removed in each pair, this step led also to removal of not only the overlapped parts but also some uniquely mapped positions. This was the reason why 16.99% of uniquely mapped positions came down to 15.46% following this step. Optional modification of the BAM files consisted of labelling of each individual BAM file with sample-specific read group name allowing both merging BAM files without any irreversible loss of specific information and also later verification analyses. Merging of individual BAM files into one "master BAM" led to a 92.51% genome coverage. Although, 4.24% of the covered genomic positions were found to have read depth below our arbitrarily set threshold of 100 mapped reads and were excluded from further analyses (Suppl. Fig. 2 ).
Finally, altogether 88.27% of the reference genome was covered with sufficient read depth for variant calling.
Following variant calling from the merged BAM file, because of statistical reasons, we decided to further analyse only variants with detected minor allele frequencies (MAF) above 5%. Under these settings we identified 6,622,893 (0.21% of the genome) unique genomic positions with potential sequence variants detected. From these, altogether 6,485,313 (97.92%) variants were already known and described in dbSNP, while 137,580 (2.08%) of them were found to be novel variants, not present in dbSNP. In general, identified variants included both SNVs, complex variants and indels, while the latter group consisted of variants having lengths <6bp, with typically shorter indels being the most common ones (Fig. 3b) .
The first step of our subsequent verification procedure included principal component analyses based comparisons of allelic frequency distributions, identified in our population sample (Slovak population located in Central Europe) to the six ExAC populations that placed our sample set most closely to the two European ExAC populations, i.e. to the Finnish and non-Finnish European population sample sets ( Fig. 3f ; Suppl. Fig. 3, 4) . Next, we compared also population frequencies of variants in a single particular gene (chloride voltage-gated channel 1; CLCN1; UniProtKB_P35523) that further suggested high reliability of variant calling and frequency determination. Specifically, we identified all but five of ExAC CLCN1 variants, having frequency >5%, in our data set too, with calculated population frequencies highly similar to those from ExAC. The exceptions were found to have ExAC frequencies around 5% (depending on population), while three of these we identified in our original data set too, although were filtered out due slightly lower than 5% frequency (Suppl. Tab. 1). In addition to these in silico verification approaches, we validated 87 positions in five polymorphic genomic loci of 58 randomly selected samples of our sample set, from which genomic DNA was available to validation purposes. These validation analyses revealed Sanger determined genotypes fully compatible with the NIPT derived allele for each of the particular loci (Suppl. Tab. 2).
Discussion
Although NIPT is generally performed using whole-genome sequencing with genome coverage well below 1x, multiply covered regions can generally be identified in individual samples.
Since these cause problems in determination of the total number of alleles for frequency calculations, we filtered out overlapping reads from our individual data sets that, as anticipated, in turn led to a lower total genome coverage. Although individual BAM files suffered by this filtration, in terms of overall genome coverage, after this filtering step we were able to set the total allele count as one allele per individual in whom the certain genomic position was 1 0 covered. Following merging of these individual BAM files into one, only 7.49% of the total possible genomic positions remained without any mapped read. The distribution of these regions showed strong correlation with unassembled regions (N's) of the genome (Fig. 2) , that is, ~4.97% for GRCh38.p10
(https://www.ncbi.nlm.nih.gov/grc/human/data?asm=GRCh38.p10). The remaining uncovered positions were likely reads unmappable even to the assembled portion of the human genome, which generally consists mainly of segmental duplications, transposable elements and structural variants (Li and Freudenberg 2014) . Further reduction in covered genomic positions, down to 88.27%, was the result of a filtering step that excluded from further analyses those regions having read depths below our arbitrarily set threshold of 100 mapped reads. When considering a typical human exome (Lek et al. 2016) , the overall coverage of our merged data set reached 97.66% before and 94.33% after the filtering for read depth.
Variant calling was finally performed from this filtered data set, while given the number of included samples, only alleles with detected minor allele frequencies (MAF) above 5% were considered for further statistical and experimental analyses. However, we anticipate that increasing the number of aggregated samples would allow to safely decrease this threshold even to rare variants which seems to be feasible especially when considering the readily increasing worldwide popularity of NIPT testing (Green et al. 2017; Shendure et al. 2017) .
Besides typical SNVs, we detected also several indel variants, mainly having lengths <6bp.
From these, shorter indels were found to be the most common that is in line with ExAC data reporting 95% of indels having length <6bp (Lek et al. 2016) . Further comparison to largescale studies, such as the 1000 Genomes Project (Altshuler et al. 2012; Auton et al. 2015) and the ExAC project (Lek et al. 2016) , did not reveal underrepresentation of indels compared to SNVs (Fig. 3d) . This suggested that one of the inherent limitations of sequencing of free-fetal DNA, stemming in the inability to detect larger indels, is not specifically relevant for NIPTbased population studies.
Since nearly 98% of the identified variants were known variants having unique entries in dbSNP, we were able to perform verification of our results on several levels. Both general and gene specific in silico population frequency comparisons, as well as validation analyses using a gold-standard method (Sanger sequencing) revealed high reliability of variant calling and allelic frequency determinations from our NIPT data. On the other hand, we identified 137,580 (2.08%) variants which were found to be not described in dbSNP. Frequency distributions of these novel variants were biased towards lower frequencies, when compared to dbSNP-known variants (Fig. 3c) , being in line with large population studies reporting novel variants having typically low frequencies (Lek et al. 2016; van Rooij et al. 2017) . Interestingly, the genomic landscape of our novel variants revealed both uniformly as well as non-uniformly distributed components (Fig. 2) . together with low complexity genomic regions, were previously found to be typical sources of sequencing or variant calling errors covering the vast majority of false indel calls (Green et al.
2017). With this regard, given that a great reduction of overall and centromere related N's in
GRCh38 against GRCh37 stemmed in low complexity and repeat rich regions (Li and Freudenberg 2014), it cannot be considered surprising that 22.14% (30,466) of our novels failed to map back to GRCh37, pointing thus to their uniqueness to GRCh38 that, on the other hand, agreed well with previous reports (Green et al. 2017) . Although this variant group may represent likely general findings, possibly consisting of both false-positives and real variants, these variants are unknown for dbSNP because of large human genome-related projects, which fuelled dbSNP, relied on variant calling against GRCh37. It should be noted, however, that none of the above characterized sources of "novelty" could be attributed to the NIPT origin of our population data and that the proportion of novel variants identified in our data set have rather technical than biological/population specific reasons.
Inherent limitations of our method should, however, also be discussed here and kept in mind during its possible future implementation. The first one is based on a recent report questioning the credibility of low-frequency variants in massively parallel sequencing based data sets, including the 1000 Genomes Project and The Cancer Genome Atlas, because of mutagenic DNA damage affecting the template DNA molecules (Chen et al. 2017 ). Since our paired-end reads did not overlap with each other because of short read lengths (35 bp), it is not possible to measure the extent of the described damage in our sample set. This effect could, however, be significantly reduced using DNA repair enzymes before library preparation that will most likely became a basic step in template preparations in general (Chen et al. 2017 ). The second possible limitation is the sample set itself. It is strongly biased towards females, since it exclusively contains women in reproductive age. It is worth noting, however, that although the original sample set contains exclusively blood samples from women, approximately 15% of reads (based on average fetal fraction), and thus also of observed alleles, belong to the fetus comprising both maternally and paternally inherited alleles. In addition, depending on the policy and possibilities of NIPT testing in each country, the sample set could be biased towards not fully physiological pregnancies, further interfering with an ideal concept of a random population sample. Since non-random population structures, based even on disease-focused consortia, are typical for large scale projects too (Lek et al. 2016) , and NIPT is likely going to replace conventional screening for selected chromosomal anomalies (Gregg et al. 2016) , neither of the above-mentioned concerns should be considered for absolute limitations. They should rather be considered and kept in mind when using NIPT-derived allelic frequencies in downstream applications such as in case of other large population studies.
On the other hand, large advantage of NIPT-based data lies in the fact that variants identified by low-coverage sequencing are practically not interpretable for individual patients.
They become interpretable only in a statistical context when they are merged into a sufficiently large data set. Our approach, in addition, allows also de-identification of the included samples by removing all the read specific metadata from the individual files. Therefore, issues of possible genetic privacy breaching through re-identification of individual patients (Erlich and Narayanan 2014) appear to be irrelevant for NIPT derived data that simplifies the consenting phase allowing truly anonymized/pseudonymized genomic data usage for general biomedical research.
It is undisputable that large-scale reference data sets of human genetic variation are crucial for different biomedical applications. Since NIPT is globally available and the number of tests carried out rapidly increase each year (Minear et al. 2015; Gregg et al. 2016) , the key important advantage of our method stems in the fact that it does not require any direct costs to generate data for large-scale population studies. It simply re-uses data already generated for other objectives thus representing a cost-effective alternative to large-scale population-specific genomic studies. Moreover, extensive cross-country data aggregation of NIPT results would represent an unprecedented source of information about worldwide frequencies of genomic variation.
Methods

Data source
The laboratory procedure used, to generate the NIPT data, were as follows: DNA from plasma of peripheral maternal blood was isolated for NIPT analysis from 1,548 pregnant women after 1 4 obtaining a written informed consent consistent with the Helsinki declaration from the subjects. pooled and sequenced using low-coverage whole-genome sequencing on an Illumina NextSeq500 platform (Illumina, San Diego, CA, USA) by performing paired end sequencing of 2x35 bases (Minarik et al. 2015) .
Data analysis
Mapping: Quality of sequenced reads was validated using reports from FastQC (v0.11.5)(Andrews 2010). Subsequently, Fastq files were mapped to human genome reference, version GRCh38.p10, using Bowtie2 (v2. haplotypes of an individual were determined in accordance to fetal fraction estimates from the NIPT trisomy testing (mean 14.45%, SD=2.50%). We randomly assigned reference-and alternative allele to the resulting 4,644 haplotypes, so that the proportion of the alternative ones matched the target MAF. We simulated sequencing process by gradually selecting samples and their alleles. Samples were selected randomly, without repetition, with probabilities proportional to their read count. Number of sample reads that cover the allele was selected randomly according to the coverage distribution of the sample. We considered only the most common coverages up to 3. In the worst-case simulated scenario, all selected reads covered an allele from the same haplotype. In the control scenario, we randomly picked alleles from the 3 individual's haplotypes without repetition. Reads were generated until targeted read depth was reached. The proportion of observed alternative alleles was then recorded as simulated MAF.
We repeated the simulation 1,000x for each targeted coverage and MAF. To remove all overlapping reads from individual BAM files, reads were filtered by a custom Python script in such way that only the first of overlapping reads was kept for further analysis.
Quality control and filtering: Summary statistics of mapping were generated using Qualimap (v2.2.1) (Okonechnikov et al. 2016) . Fragments with low mapping quality (MAPQ < 21) or inconsistent mapping of corresponding reads in pair were removed using Bamtools (Barnett et al. 2011) . Filtered BAM files were merged into a single BAM file using the samtools merge. 
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